Low toxic agents for treatment of B-Cell Lymphomas and Leishmaniasis
Search for novel natural products from the extracts of various parts of plants is still an important pillar of modern drug research. Plants of the families Dioncophyllaceae and Ancistrocladaceae are the only producers of Naphtho¬quinones. These novel lead candidates can be used as antitumoral agents for the treatment of B-cell lymphoma or multiple myeloma and as antiinfectives against malaria, African sleeping sickness, Chagas disease or leishma¬niasis.
<p> The novel lead substances can be used as antitumoral agents for the treatment of B-cell lymphoma or multiple myeloma. In vitro tests prove significantly reduced cell poliferation in tumor cell lines of aggressive B-Cell lymphomas as well as MM whereas they are non-toxic against normal peripheralmono-nuclear blood cells. <p> The compounds are attractive leads for the treatment of multiple myeloma which is the second most frequent hematological form of tumor and offer an alternative to the anti-CD20 treatment strategies. <p>
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Targeting failure with new polymer technology to enhance sustainability
Sustainability is a complex problem with many different players and influenced by policies, society, and technical perspective. We are reminded every day in the media of the unnecessary amount of…
Solar-powered desalination system requires no extra batteries
Because it doesn’t need expensive energy storage for times without sunshine, the technology could provide communities with drinking water at low costs. MIT engineers have built a new desalination system that…
What we can learn from hungry yeast cells
EMBL Heidelberg and University of Virginia scientists have discovered a curious way in which cells adapt to starvation – a mechanism with potential cancer implications. What can stressed yeast teach…
